| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ca060f30a9098d43c55d868ec47cef7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9caadfadd2e7bf3aaf32e68b8676ea07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a74e5881d77006143ad2aff6180f5d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_986fd569a7f82f4f1a458af8267a7d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6040837f9e9ee1d27c6ae4437f2ab62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40e734040a35a1615da69dbcb33b3f79 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2007-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3a94bbac6d52680529f8e8c973471d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa30e8eb92c38faabc4a93056278f704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_024f4afda01b692bf0ee0762340eceb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86466445714692ce9219a7ed4aacd5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7a6415d8b8c99783c2c3fcef24ba275 |
| publicationDate |
2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008115254-A1 |
| titleOfInvention |
Method of protecting against staphylococcal infection |
| abstract |
A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate of PS1 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus epidermidis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2501403-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2501403-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010320031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013510882-A |
| priorityDate |
2006-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |